Why Biogen Stock Topped the Market Today

One of these enterprises was Biogen (NASDAQ: BIIB), which did quite well in its second quarter. As a reward, investors snapped up the stock, sending it to a nearly 2% gain on the day. This beat the S&P 500 index's 0.2% rise.Before market open that day, Biogen published those quarterly figures. For the period, the big biotech's revenue was $2.7 billion, 3% higher year over year. The story was quite different on the bottom line, as net income not under generally accepted accounting principles (non-GAAP, or adjusted) slipped to $536 million, or $3.60 per share, from the year-ago profit of $803 million. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool